This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
At the recent spring meeting of the American Academy of Facial Plastic and Reconstructive Surgery in Palm Beach, Fla, Dr David B. Hom, Ypsilanti, Mich, and Drs Shan R. Baker, Linda M. Graham, and Ken D. McClutchey, Ann Arbor, Mich, presented a study utilizing angiogenic agents to enhance the neovascularization of skin flaps. Their purpose was to determine if and what optimum concentration of angiogenic agents can speed up neovascularization. Endothelial cell–growth supplement applied topically, with and without gel foam, and endothelial cell–growth factor were the agents studied. White rabbits' ears were used and island flaps were raised, based on the radial artery distribution. On day 3 postoperatively, the central vascular pedicle was ligated. On day 10 postoperatively, the carotid arteries were cannulated, and the dye was continuously infused. Statistically, significant results were obtained in the endothelial cell–growth supplement plus gel foam–treated flaps vs the control or nontreated flaps.
PERKINS SW. Utilizing Angiogenic Agents to Enhance and Expedite the Neovascularization Process in Skin Flaps. Arch Otolaryngol Head Neck Surg. 1988;114(11):1228–1229. doi:10.1001/archotol.1988.01860230022008
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: